Literature DB >> 23051809

Patterns of technological innovation in biotech.

Laura M McNamee1, Fred D Ledley.   

Abstract

Mesh:

Substances:

Year:  2012        PMID: 23051809     DOI: 10.1038/nbt.2389

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  13 in total

Review 1.  Approaches for the sequence-specific knockdown of mRNA.

Authors:  Lisa J Scherer; John J Rossi
Journal:  Nat Biotechnol       Date:  2003-12       Impact factor: 54.908

Review 2.  Development trends for human monoclonal antibody therapeutics.

Authors:  Aaron L Nelson; Eugen Dhimolea; Janice M Reichert
Journal:  Nat Rev Drug Discov       Date:  2010-09-03       Impact factor: 84.694

Review 3.  Chemical modification of gene silencing oligonucleotides for drug discovery and development.

Authors:  Xiaolan Chen; Nancy Dudgeon; Long Shen; Jui H Wang
Journal:  Drug Discov Today       Date:  2005-04-15       Impact factor: 7.851

4.  The problem with potency.

Authors:  Christopher Thomas Scott
Journal:  Nat Biotechnol       Date:  2005-09       Impact factor: 54.908

5.  The growth of the cell death field: an analysis from the ISI-Science citation index.

Authors:  E Garfield; G Melino
Journal:  Cell Death Differ       Date:  1997-07       Impact factor: 15.828

Review 6.  Viral gene therapy strategies: from basic science to clinical application.

Authors:  Lawrence S Young; Peter F Searle; David Onion; Vivien Mautner
Journal:  J Pathol       Date:  2006-01       Impact factor: 7.996

Review 7.  Lessons from 60 years of pharmaceutical innovation.

Authors:  Bernard Munos
Journal:  Nat Rev Drug Discov       Date:  2009-12       Impact factor: 84.694

8.  Commercializing a disruptive technology.

Authors:  Simcha Jong
Journal:  Nat Biotechnol       Date:  2011-08       Impact factor: 54.908

9.  Gene therapy for human genetic disease?

Authors:  T Friedmann; R Roblin
Journal:  Science       Date:  1972-03-03       Impact factor: 47.728

Review 10.  Can literature analysis identify innovation drivers in drug discovery?

Authors:  Pankaj Agarwal; David B Searls
Journal:  Nat Rev Drug Discov       Date:  2009-11       Impact factor: 84.694

View more
  9 in total

1.  Making the biotech IPO work.

Authors:  Laura McNamee; Fred Ledley
Journal:  Nat Biotechnol       Date:  2013-11       Impact factor: 54.908

Review 2.  Cancer nanomedicines: so many papers and so few drugs!

Authors:  Vincent J Venditto; Francis C Szoka
Journal:  Adv Drug Deliv Rev       Date:  2012-10-01       Impact factor: 15.470

3.  Translational science by public biotechnology companies in the IPO "class of 2000": the impact of technological maturity.

Authors:  Laura McNamee; Fred Ledley
Journal:  PLoS One       Date:  2013-12-16       Impact factor: 3.240

4.  Timelines of translational science: From technology initiation to FDA approval.

Authors:  Laura M McNamee; Michael Jay Walsh; Fred D Ledley
Journal:  PLoS One       Date:  2017-05-08       Impact factor: 3.240

5.  Modeling timelines for translational science in cancer; the impact of technological maturation.

Authors:  Laura M McNamee; Fred D Ledley
Journal:  PLoS One       Date:  2017-03-27       Impact factor: 3.240

6.  Contribution of NIH funding to new drug approvals 2010-2016.

Authors:  Ekaterina Galkina Cleary; Jennifer M Beierlein; Navleen Surjit Khanuja; Laura M McNamee; Fred D Ledley
Journal:  Proc Natl Acad Sci U S A       Date:  2018-02-12       Impact factor: 11.205

7.  The life-cycles of skin replacement technologies.

Authors:  Mihail Climov; Adriana C Panayi; Gregory Borah; Dennis P Orgill
Journal:  PLoS One       Date:  2020-03-04       Impact factor: 3.240

8.  As Technologies for Nucleotide Therapeutics Mature, Products Emerge.

Authors:  Jennifer M Beierlein; Laura M McNamee; Fred D Ledley
Journal:  Mol Ther Nucleic Acids       Date:  2017-10-28

Review 9.  Medical Micro/Nanorobots in Precision Medicine.

Authors:  Fernando Soto; Jie Wang; Rajib Ahmed; Utkan Demirci
Journal:  Adv Sci (Weinh)       Date:  2020-10-04       Impact factor: 16.806

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.